Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma

NCT03614364 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Salivary Duct Carcinoma

Interventions

DRUG: nanoxel
DRUG: herzuma

Sponsor

Samsung Medical Center